Skip to main content
. 2019 Jan 8;19(3):1471–1480. doi: 10.3892/mmr.2019.9831

Table I.

Culture methods for γδ T cell expansion since 2000.

Author, year Cell source Stimulant Cytokines (concentration) Relative increase in the number of cells (times) Duration of culture (days) Refs.
Duault et al, 2016 PBMC BrHPP IL-2 (400 U/ml), IL-33 (100, 500 or 1,000 ng/ml) 10-12 10 (40)
Klimpel et al, 2003 PBMC None IL-2 (100 U/ml), IL-15 (1,000 U/ml) 10-12 8 (41)
Kondo et al, 2011 PBMC Zoledronate (Zometa) IL-2 (1,000 U/ml) 12-16 14 (24,42)
Sato et al, 2009
Barcy et al, 2008 PBMC None IL-2 (20 U/ml) IL-7 (100 U/ml) 6-8 14 (43)
Rincon-Orozco et al, 2005 PBMC IPP IL-2 (100 U/ml) 14 (44)
Cabillic et al, 2010 PBMC BrHPP/Zoledronate (Zometa) IL-2 (400 U/ml) 12-14 14 (45)
Casetti et al, 2009 PBMC IPP IL-2 (6.5 U/ml), IL-15 (10 ng/ml), TNF-α (1.7 ng/ml) 6-8 10 (46)
Devilder et al, 2009 PBMC Phytohemagglutinin None 6-8 (47)
Tsai et al 2015 Magnetically isolated γδ T cells None None (48)
McGill et al, 2016 Magnetically isolated γδ T cells None IL-2 (10 U/ml) 8-10 (49)

BrHPP, bromohydrin pyrophosphate; IL, interleukin; IPP, isopentenyl pyrophosphate; PBMC, peripheral blood mononuclear cell; TNF-α, tumor necrosis factor α.